NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1992737191 MD
Verify on CMS → Matthew Curley, MD
Pulmonary Disease Physician in Manchester, New Hampshire.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 285 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.6/100
▼ 2 pts below national avg 83.5 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Matthew Curley, MD reported a CMS MIPS final score of 81.6/100 - below the 83.5 national average - and filed 1,147 Medicare Part D claims in 2024.
- 81.6/100
- MIPS score · -2 vs avg
- 1K
- Part D claims, 2024
- 41%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Curley, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1992737191), first enumerated 07/07/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,147 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 81.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1992737191 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1992737191
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- MIPS-INLINE 81.6/100
- RX-MID 1,147
- BOOK-THIN 45 in New Hampshire
- PHOTO-FINISH Ioana Amzuta · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Curley · this pr…
Curley · this provider
81.6 MIPS pts
- Manju Paul · hig…
Manju Paul
81.6 MIPS pts
- Ioana Amzuta · n…
Ioana Amzuta
81.6 MIPS pts
- Kumar Ashutosh ·…
Kumar Ashutosh
81.6 MIPS pts
- Sumendra Joshi ·…
Sumendra Joshi
81.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Matthew Curley, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
82 ≥ 32nd percentile 32% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Matthew Curley, MD sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Curley, MD writes more Part D claims than 54% of them and scores higher on MIPS quality than 39% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Matthew Curley, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Matthew Curley, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Curley, MD?
Near national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
1,147 23% vs specialty avg
MIPS final score
81.6/100 1.9 pts vs avg
Specialty distribution in New Hampshire
How Pulmonary Disease Physician compares to other specialties among New Hampshire providers
Medicare quality performance, MIPS
Matthew Curley, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 81.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1992737191 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/07/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
81.6481
Final Score
Measured-score avg: 83.5
79.0846
Quality
59.7424
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Matthew Curley, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Matthew Curley, MD is affiliated with 3 Medicare-billing facilities, 1 of which carry a CMS Hospital overall star rating.
Mary Hitchcock Memorial Hospital
★★★☆☆ 3/5
Lebanon, NH
Acute Care Hospitals
CMS CCN: 300003
Dartmouth-Hitchcock Clinic
Manchester, NH
Intensive Care Consortium Inc
Portsmouth, NH
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Brand-heavy
Matthew Curley, MD - brand share 59.0%
Pulmonary Disease Physician average
59% brand-name claims vs 41% generic, on 1,147 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,147
Total Claims
$715K
Total Drug Cost
285
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,616.867
- Total Day Supply
- 46,173
- Brand vs Generic
- 59% brand / 41% generic
- Brand Drug Cost
- $684K
- Generic Drug Cost
- $31K
- Antibiotic Claims
- 34
Patient Demographics
- Average Patient Age
- 71.0 years
- Avg HCC Risk Score
- 1.71
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 51, 65-74: 131, 75-84: 90, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Curley, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
174 claims
- Trelegy Ellipta
Trelegy Ellipta
108 claims
- Anoro Ellipta
Anoro Ellipta
87 claims
- Montelukast Sodium 61
Montelukast Sodium
61 claims
- Wixela Inhub 52
Wixela Inhub
52 claims
- Prednisone 50
Prednisone
50 claims
- Breo Ellipta 46
Breo Ellipta
46 claims
- Fluticasone-Salmet… 42
Fluticasone-Salmeterol
42 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 174 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 108 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 87 |
| Montelukast Sodium | 61 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 52 |
| Prednisone | 50 |
| Breo Ellipta Fluticasone/Vilanterol | 46 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 42 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 35 |
| Spiriva Respimat Tiotropium Bromide | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Matthew Curley, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Matthew Curley, MD's 1,147 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Curley, both outside New Hampshire so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (81.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in New Hampshire
Other clinicians with the same primary specialty enrolled in New Hampshire, drawn from the same CMS NPPES roster as Curley.
One of 45 Pulmonary Disease Physician providers enrolled in New Hampshire, 5 are shown here.
Dr. Fady Abou Rizk
MD
Laconia, NH
Dr. D. Akey
MD
Concord, NH
Dr. Ali Al-Alwan
MD
Dover, NH
Daniel Aridgides
M.D. PH.D.
Lebanon, NH
Dr. Graham Atkins
MD
Lebanon, NH
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Curley, MD's specialty? ▼
Matthew Curley, MD specializes in Pulmonary Disease Physician and practices in Manchester, New Hampshire. Credentials: MD.
How much does Matthew Curley, MD prescribe under Medicare Part D? ▼
In 2024, Matthew Curley, MD wrote 1,147 Medicare Part D claims totaling $715K in drug costs for 285 beneficiaries.
What is Matthew Curley, MD's Medicare quality score? ▼
Matthew Curley, MD has a CMS MIPS Final Score of 81.6/100 (Quality: 79.1, Cost: 59.7). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Matthew Curley, MD located? ▼
Matthew Curley, MD is located at 87 MCGREGOR STREET, Manchester, NH, 03102. Phone: (603) 645-6407.
What is Matthew Curley, MD's NPI number? ▼
Matthew Curley, MD's National Provider Identifier (NPI) is 1992737191, issued on 07/07/2006.
Does Matthew Curley, MD prescribe more brand-name or generic drugs? ▼
Matthew Curley, MD's prescribing is 59% brand-name and 41% generic drugs by claim count, with $684K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Matthew Curley, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Curley, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Trelegy Ellipta, Anoro Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Curley, MD accept Medicare? ▼
Matthew Curley, MD appears in CMS Medicare data with 1,147 Part D claims and 285 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Curley, MD's credentials? ▼
Matthew Curley, MD's NPI is 1992737191 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.